These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38612500)

  • 1. Retinal Neurodegeneration in an Intraocular Pressure Fluctuation Rat Model.
    Han JS; Park CK; Jung KI
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular pressure fluctuation and neurodegeneration in the diabetic rat retina.
    Jung KI; Woo JE; Park CK
    Br J Pharmacol; 2020 Jul; 177(13):3046-3059. PubMed ID: 32087615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous Meg2 Ablation Causes Intraocular Pressure Elevation and Progressive Glaucomatous Neurodegeneration.
    Reinhard J; Wiemann S; Joachim SC; Palmhof M; Woestmann J; Denecke B; Wang Y; Downey GP; Faissner A
    Mol Neurobiol; 2019 Jun; 56(6):4322-4345. PubMed ID: 30315478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the endothelin A (ET
    McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
    BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
    Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
    Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal chelator combined with permeability enhancer ameliorates oxidative stress-associated neurodegeneration in rat eyes with elevated intraocular pressure.
    Liu P; Zhang M; Shoeb M; Hogan D; Tang L; Syed MF; Wang CZ; Campbell GA; Ansari NH
    Free Radic Biol Med; 2014 Apr; 69():289-99. PubMed ID: 24509160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effect of alpha(2) agonist (brimonidine) on adult rat retinal ganglion cells after increased intraocular pressure.
    Ahmed FA; Hegazy K; Chaudhary P; Sharma SC
    Brain Res; 2001 Sep; 913(2):133-9. PubMed ID: 11549376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of triptolide on retinal ganglion cells in a rat model of chronic glaucoma.
    Yang F; Wang D; Wu L; Li Y
    Drug Des Devel Ther; 2015; 9():6095-107. PubMed ID: 26604697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical administration of rapamycin promotes retinal ganglion cell survival and reduces intraocular pressure in a rat glaucoma model.
    Wang F; Ma F; Song Y; Li N; Li X; Pang Y; Hu P; Shao A; Deng C; Zhang X
    Eur J Pharmacol; 2020 Oct; 884():173369. PubMed ID: 32712092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma.
    Roh M; Zhang Y; Murakami Y; Thanos A; Lee SC; Vavvas DG; Benowitz LI; Miller JW
    PLoS One; 2012; 7(7):e40065. PubMed ID: 22802951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma.
    Naskar R; Wissing M; Thanos S
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2962-8. PubMed ID: 12202516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
    Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
    Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension.
    Day DG; Hollander DA
    Curr Med Res Opin; 2008 May; 24(5):1435-42. PubMed ID: 18402717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The elevation of intraocular pressure is associated with apoptosis and increased immunoreactivity for nitric oxide synthase in rat retina whereas the effectiveness of retina derived relaxing factor is unaffected.
    Takır S; Gürel-Gürevin E; Toprak A; Demirci-Tansel C; Uydeş-Doğan BS
    Exp Eye Res; 2016 Apr; 145():401-411. PubMed ID: 26948455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a non-selective beta-blocker on adult rat anterograde axonal transport and retinal ganglion layer after increased intraocular pressure.
    Díaz F; Villena A; Moreno M; Vidal L; Parrado C; García-Campos J; de Vargas IP
    Histol Histopathol; 2005 Oct; 20(4):1077-84. PubMed ID: 16136490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.
    Seki M; Tanaka T; Matsuda H; Togano T; Hashimoto K; Ueda J; Fukuchi T; Abe H
    Br J Ophthalmol; 2005 Apr; 89(4):504-7. PubMed ID: 15774933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma.
    Neufeld AH; Sawada A; Becker B
    Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9944-8. PubMed ID: 10449799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of intraocular pressure elevation in a modified laser-induced glaucoma rat model.
    Biermann J; van Oterendorp C; Stoykow C; Volz C; Jehle T; Boehringer D; Lagrèze WA
    Exp Eye Res; 2012 Nov; 104():7-14. PubMed ID: 22981807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of thioredoxins 1 and 2 increases retinal ganglion cell survival after pharmacologically induced oxidative stress, optic nerve transection, and in experimental glaucoma.
    Caprioli J; Munemasa Y; Kwong JM; Piri N
    Trans Am Ophthalmol Soc; 2009 Dec; 107():161-5. PubMed ID: 20126492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
    Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
    Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.